BD explores plastic blood tube recycling

Becton, Dickinson and Co. (NYSE:BDX) will explore blood tube recycling in a sustainability pilot program. BD’s partners include Odense University Hospital, the Health Innovation Centre of Southern Denmark, Danish Technological Institute, and GMAF Circular Medico/EcoFitt. These plastic blood collection tubes are made from high-quality raw materials, but are incinerated with other biohazardous waste after use. The blood tube recycling pilot program will investigate the steps for recycling the tubes, including an evaluation of the recycled plastic’s quality and safety and hygiene precautions. BD is the world’s largest manufacturer of evacuated blood collection tubes, BD Sustainable Medical Technology Institute Amit Limaye said. “As part of our 2030+ environmental, social and governance goals, we are focused on reducing the environmental impact of our product portfolio,” Limaye said in a news release. “This partnership and program are a great example of like-minded stakeholders coming together to drive progress toward a greener, more sustainable health care system, because success cannot be accomplished by any one stakeholder alone.” Denmark’s Climate Action Strategy’s goal is to cut the nation’s greenhouse gas emissions by 70% in 2030 compared to 1990 levels. “Hospitals in Denmark are an active participant in the country’s green agenda, and knowing that blood collection tubes are one of healthcare’s most commonly used products, we saw an opportunity to explore a solution that would allow for these tubes to be recycled,” Mads Nybo, chief physician of the Department of Clinical Biochemistry at Odense University Hospital, said in the news release. BD’s medical segment is the 14th-largest medical device company by revenue, according to the Medical Design & Outsourcing 2022 Medtech Big 100 list.
更多内容,请访问原始网站
文中所述内容并不反映新药情报库及其所属公司任何意见及观点,如有版权侵扰或错误之处,请及时联系我们,我们会在24小时内配合处理。
适应症
-
靶点
-
药物
-
来和芽仔聊天吧
立即开始免费试用!
智慧芽新药情报库是智慧芽专为生命科学人士构建的基于AI的创新药情报平台,助您全方位提升您的研发与决策效率。
立即开始数据试用!
智慧芽新药库数据也通过智慧芽数据服务平台,以API或者数据包形式对外开放,助您更加充分利用智慧芽新药情报信息。